Literature DB >> 24657886

Platelet 5-HT(1A) receptor correlates with major depressive disorder in drug-free patients.

Zhang-Jin Zhang1, Di Wang2, Sui Cheung Man3, Roger Ng4, Grainne M McAlonan5, Hei Kiu Wong3, Wendy Wong3, Jade Lee3, Qing-Rong Tan6.   

Abstract

The platelet serotonergic system has potential biomarker utility for major depressive disorder (MDD). In the present study, platelet expression of 5-HT1A receptors and serotonin transporter (SERT) proteins, and serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) were quantified in 53 patients with MDD and 22 unaffected controls. All were drug-free, non-smokers and had no other psychiatric and cardiovascular comorbidity. The severity of depression symptoms was evaluated using the 17-item Hamilton Depression Rating Scale (HAMD-17) and the Self-rating Depression Scale (SDS). Patients with MDD had significantly higher expression of platelet 5-HT1A receptors but significantly lower contents of platelet 5-HT, platelet-poor plasma (PPP) 5-HT and PPP 5-HIAA compared to healthy controls, and this was correlated with the severity of depression. SERT expression did not differ between the two groups. Correlation analysis confirmed a strong, inverse relationship between the 5-HT1A receptor expression and the 5-HT and 5-HIAA levels. Thus overexpression of platelet 5-HT1A receptors and reduced 5-HT tone may function as a peripheral marker of depression.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-HT(1A) receptor; 5-Hydroxyindoleacetic acid (5-HIAA); Major depressive disorder; Platelet; Serotonin

Mesh:

Substances:

Year:  2014        PMID: 24657886     DOI: 10.1016/j.pnpbp.2014.03.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males.

Authors:  Joshua Kaufman; Gregory M Sullivan; Jie Yang; R Todd Ogden; Jeffrey M Miller; Maria A Oquendo; J John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

Review 2.  Association between homocysteine levels in acute stroke and poststroke depression: A systematic review and meta-analysis.

Authors:  Yupei Chen; Hua Zou; Meidi Peng; Yan Chen
Journal:  Brain Behav       Date:  2022-05-23       Impact factor: 3.405

Review 3.  Suggested Biomarkers for Major Depressive Disorder.

Authors:  Yunus Hacimusalar; Ertuğrul Eşel
Journal:  Noro Psikiyatr Ars       Date:  2018-05-28       Impact factor: 1.339

4.  Prioritization and comprehensive analysis of genes related to major depressive disorder.

Authors:  Yi Liu; Pengfei Fan; Shiyuan Zhang; Yidan Wang; Dan Liu
Journal:  Mol Genet Genomic Med       Date:  2019-04-09       Impact factor: 2.183

5.  The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse.

Authors:  Dubravka Svob Strac; Gordana Nedic Erjavec; Matea Nikolac Perkovic; Korona Nenadic-Sviglin; Marcela Konjevod; Mirko Grubor; Nela Pivac
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-24       Impact factor: 2.570

6.  Serotonin Receptor and Transporter Endocytosis Is an Important Factor in the Cellular Basis of Depression and Anxiety.

Authors:  Nikita Deo; Gregory Redpath
Journal:  Front Cell Neurosci       Date:  2022-02-24       Impact factor: 5.505

Review 7.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.